Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutations01:39

Mutations

94.5K
Overview
94.5K
Classifying Matter by State02:49

Classifying Matter by State

103.6K
Chemistry is the study of matter and the changes it undergoes. Matter is anything that has mass and occupies space. Matter is all around us; the air, water, soil, mountains, even our bodies are all examples of matter. Matter is divided into three states — solid, liquid, and gas — that are commonly found on earth. The fourth state of matter, plasma, occurs naturally in the interiors of stars. 
103.6K
Classifying Matter by Composition03:35

Classifying Matter by Composition

90.6K
Matter: Pure Substances and Mixtures
According to its composition, the matter can be classified into two broad categories — pure substances and mixtures. 
A pure substance is a form of matter that has a constant composition throughout with uniform properties. For example, any sample of sucrose has the same composition and same physical properties, such as melting point, color, and sweetness, regardless of the source from which it is isolated. 
A mixture is composed of two or...
90.6K
Wood Panel Products01:18

Wood Panel Products

393
Wood panel products are essential materials used in construction for applications such as flooring, siding, and roofing, typically available in standard dimensions of 4 feet by 8 feet, with thicknesses varying from one-quarter of an inch to one and one-eighth inches. Among the most common types of wood panels is plywood, which is produced by gluing multiple layers of thin wood veneers under pressure. The grain of the outer veneers runs lengthwise, while the grains of the interior layers run...
393
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

458
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
458
Viral Mutations00:36

Viral Mutations

39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Response to the Letter to the Editor: Population-informed Assessment of Clonality in Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Lung Cancer Patients Display Increased Expression of Bovine Meat and Milk Factor (BMMF) Proteins in Peritumor Alveolar Macrophages.

International journal of cancer·2026
Same author

Pulmonary Actinomycosis: A Hidden Threat with Clinical Impact.

Advances in respiratory medicine·2026
Same author

Functional Precision Oncology Approach Using Nanoliter Droplet Array for Drug Sensitivity Testing in Lung Cancer.

Advanced healthcare materials·2026
Same author

ATM Deficiency Induces TGF-β-Mediated Stromal Programming in Pancreatic Cancer.

Cancer research·2026
Same author

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Med (New York, N.Y.)·2026

Related Experiment Video

Updated: Feb 5, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

3.0K

Size matters: Dissecting key parameters for panel-based tumor mutational burden analysis.

Ivo Buchhalter1,2, Eugen Rempel1, Volker Endris1

  • 1Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.

International Journal of Cancer
|September 22, 2018
PubMed
Summary
This summary is machine-generated.

Tumor mutational burden (TMB) estimation using gene panels is crucial for predicting response to immune checkpoint blockade. Panels between 1.5 and 3 Mbp offer optimal precision for TMB assessment in clinical diagnostics.

Keywords:
NGSTMBmutational loadpanelsequencingtumor mutational burden

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.1K
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
07:12

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Published on: July 7, 2016

21.0K

Related Experiment Videos

Last Updated: Feb 5, 2026

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

3.0K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.1K
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
07:12

Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models

Published on: July 7, 2016

21.0K

Area of Science:

  • Oncology
  • Genomics
  • Immunotherapy

Background:

  • Tumor mutational burden (TMB) is a key biomarker for predicting response to immune checkpoint blockade (ICB).
  • While comprehensive genomic profiling provides accurate TMB measurement, gene panel sequencing offers practical advantages for routine diagnostics.
  • Limited data exists on factors influencing the accuracy of panel-based TMB estimation.

Purpose of the Study:

  • To investigate the impact of gene panel size and composition on TMB estimation accuracy.
  • To evaluate the performance of the Illumina TSO500 panel for TMB assessment.
  • To propose optimal panel sizes and dynamic cutoff values for TMB determination.

Main Methods:

  • In silico analysis of The Cancer Genome Atlas (TCGA) dataset simulating various gene panel sizes and compositions.
  • Evaluation of the Illumina TSO500 gene panel.
  • Analysis of parameters including confidence intervals, cutoff values, sensitivity, specificity, and positive predictive value.

Main Results:

  • Panel size significantly impacts confidence intervals, cutoff values, and diagnostic test performance.
  • Panels between 1.5 and 3 Mbp provide precise TMB estimates with small confidence intervals.
  • Smaller panels (<1.5 Mbp) yield imprecise TMB estimates, particularly for low to moderate TMB levels, hindering discrimination between hypermutated and non-hypermutated tumors.

Conclusions:

  • Gene panel size is a critical factor for reliable TMB estimation in clinical practice.
  • 1.5-3 Mbp gene panels are recommended for accurate TMB assessment, balancing cost and precision.
  • Dynamic, entity-specific cutoff values should be considered for optimal interpretation of TMB results.